Use of Modeling and Simulation in the Design and Conduct of Pediatric Clinical Trials and the Optimization of Individualized Dosing Regimens.
about
Clinical Trial Design in Juvenile Idiopathic Arthritis.Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.Model-Based Approach for Optimizing Study Design and Clinical Drug Performances of Extended-Release Formulations of Methylphenidate for the Treatment of ADHD.Design and conduct of early phase drug studies in children: challenges and opportunitiesMethodological and Ethical Issues in Pediatric Medication Safety Research.
P2860
Use of Modeling and Simulation in the Design and Conduct of Pediatric Clinical Trials and the Optimization of Individualized Dosing Regimens.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Use of Modeling and Simulation ...... ndividualized Dosing Regimens.
@ast
Use of Modeling and Simulation ...... ndividualized Dosing Regimens.
@en
type
label
Use of Modeling and Simulation ...... ndividualized Dosing Regimens.
@ast
Use of Modeling and Simulation ...... ndividualized Dosing Regimens.
@en
prefLabel
Use of Modeling and Simulation ...... ndividualized Dosing Regimens.
@ast
Use of Modeling and Simulation ...... ndividualized Dosing Regimens.
@en
P2093
P2860
P356
P1476
Use of Modeling and Simulation ...... Individualized Dosing Regimens
@en
P2093
C Stockmann
J K Roberts
J S Barrett
P2860
P304
P356
10.1002/PSP4.12038
P577
2015-11-13T00:00:00Z